Enrollment finished 6 months ahead of schedule
CASE 01 · GLOBAL PHASE III NEPHROLOGY
−12%
SCREEN FAILURES VS. EXPECTED
58
PATIENTS RETAINED
8%
RESCREEN RATE VS. 30% AVG.
CHALLENGES
- Comparable study saw testing hold queries for 100% of screening samples
- Sponsor team manually called sites daily for shipment updates
- Sample deviations, lost samples, and tracking gaps delayed enrollment
WITH TRULAB
- 25 randomization risks resolved
- Lab testing hold queries resolved within 2 hours
- Screening/primary endpoint sample errors caught and escalated
"I can't thank you enough! You likely just saved our first patient screened!"
